Gyros Protein Technologies AB

https://www.gyros.com

Twitter: @GyrosProteinTec

LinkedIn: https://www.linkedin.com/company/gyros-protein-technologies-ab

Gyros Protein Technologies is a leading provider of sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. Formed in March 2016 by the merger of Gyros AB and Protein Technologies, Inc., the Company combines Gyros’ microfluidics, systems development and immunoassay expertise with Protein Technologies’ deep knowledge in developing and manufacturing instruments for peptide synthesis. With a large and growing installed base of instruments in the biopharmaceutical industry, as well as with CRO and CMO partners, Gyros Protein Technologies is leading its field in several key application areas in biotherapeutics, from research through Phase 4 clinical development and particularly in bioprocess. The Company holds a high growth, high margin product portfolio, including ~50% in recurring aftermarket consumables and service revenue, coupled with a reputation for exceptional customer service and support. Gyros Protein Technologies has over 100 employees across the USA and Europe, and has development and manufacturing facilities in Uppsala, Sweden and Tucson, AZ, and a commercial site in Warren, NJ. Current majority shareholders of both Gyros AB and Protein Technologies, Inc., which are the AP6 and Ampersand Capital Partners respectively, become the major shareholders in Gyros Protein Technologies AB. *

	Start	2016-03-16 renamed date ca
	Predecessor	Gyros AB
	Industry	Gyros™ immunoassay platform
	Person	Calvo, Daniel J. (Dan) (Gyros 201310– CEO before Omcimmune USA + Assay Designs + Cellomics + PerkinElmer)
	Person 2	Patteson, David B. (Dave) (Ampersand Capital 2015– Operating Partner before Advion + Biotage + Foxboro Company)

	Region	Uppsala
	Country	Sweden
	Street	54B Dag Hammarskjölds väg Uppsala Science Park
	City	75183 Uppsala
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2011-08-31)
	Currency	USD
	Annual sales	38,000,000 (revenues (2019c) 2019-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2019-11-16

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Picture EBD Group Global Partnering Four Events One Price 650x80

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Associations

Advertise

Gyros Protein Technologies AB